Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Food Recall Warning (Allergen) - Laskol brand Chrzan recalled due to undeclared milk


Product photos are available at http://www.inspection.gc.ca/eng/1558481720205/1558481720958

OTTAWA, May 21, 2019 /CNW/ - Polish Trade Centre Ltd. is recalling Laskol brand Chrzan from the marketplace because it contains milk which is not declared on the label. People with an allergy to milk should not consume the recalled product described below.

The following product has been sold in Alberta, Manitoba, and Ontario.

Recalled product

 

Brand

Product

Size

UPC

Codes

Laskol

Chrzan

(Horseradish with citrus acid)

290 g

5 902556 001126

All codes where milk is not declared on the label

 

What you should do

Check to see if you have recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

If you have an allergy to milk, do not consume the recalled product as it may cause a serious or life-threatening reaction.

Background

This recall was triggered by a consumer complaint. The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing recalled product from the marketplace.

Reactions

There have been no reported reactions associated with the consumption of this product.

More information

 

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...



News published on and distributed by: